Some short talks presented at previous East Bay Biosecurity meetups. If you are interested in giving a short talk in the future, please e-mail us at eastbaybiosec@gmail.com.

Breaking Down the Risks of Life Sciences Research

The responsible conduct of life sciences research involves not only being cognizant of the myriad benefits of the research, but also the risks. What kinds of risks are generated from life sciences research, and how can we prioritize among them? Brian Wang touches on these questions in this talk.

What Can Biohacking Look Like in 2018?

What can be done with biohacking in 2018? Tessa Alexanian presents a few different possibilities based on her recent experience in the Biohacking Village at Defcon 2018.

The US Federal Select Agent Program

This is a short talk presented by Brian Wang on the history of, an overview of, and criticisms of the US Federal Select Agent Program.

Information Hazard Types and Biological Risk Examples

Some kinds of information can be quite dangerous if they fall into the wrong hands. What is the nature of these "information hazards," and how do they apply to the biosecurity context? Megan Crawford presents some thoughts on these questions in this short talk.

Nature’s Source Code is Vulnerable and Can’t be Patched

What new risks can we expect to face given that the human engineering of organisms is free from evolutionary design constraints, and what we can do to mitigate them? Jeffrey Ladish addresses these questions in this talk.

Gene Editing in Humans

This short talk by Samira Nedungadi presents the current techniques of, the therapeutic applications of, and the history of gene editing in humans.

Cyber Kill Chain: Can We Adapt This Idea to Biosecurity?

Can the concept of a “cyber kill chain” be applied to biosecurity? Megan Crawford presents some similarities and differences between the kill chains relevant to cyber- and biosecurity based on a talk she attended at Defcon 2018.

Summer Workshop Report: Three Case Studies on the Risks of Overreaction

This talk by Brian Wang presents three case studies on the risks of overreaction to biological risks.